Anti-tumor immunity elicited by direct intratumoral administration of a recombinant adenovirus expressing either IL-28A/IFN-λ2 or IL-29/IFN-λ1.-论文-万方医学网

第一作者： K,Hasegawa

第一单位： Laboratory of Clinical Science and Biomedicine, Faculty of Pharmaceutical Sciences, Josai University, Sakado, Japan.

作者： K,Hasegawa ^[1] ; M,Tagawa ^[2] ; K,Takagi ^[3] ; H,Tsukamoto ^[4] ; Y,Tomioka ^[4] ; T,Suzuki ^[3] ; Y,Nishioka ^[5] ; T,Ohrui ^[6] ; M,Numasaki ^[1]

作者单位： Laboratory of Clinical Science and Biomedicine, Faculty of Pharmaceutical Sciences, Josai University, Sakado, Japan. ^[1] Division of Pathology and Cell Therapy, Chiba Cancer Center Research Institute, Chiba, Japan. ^[2] Departments of Pathology and Histotechnology, Tohoku University Graduate School of Medicine, Sendai, Japan. ^[3] Laboratory of Oncology, Pharmacy Practice and Sciences, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan. ^[4] Department of Respiratory Medicine and Rheumatology, Institute of Health Biosciences, University of Tokushima Graduate School, Tokushima, Japan. ^[5] Division of Geriatric Pharmacotherapy, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan. ^[6]

医学主题词腺病毒科(Adenoviridae);动物(Animals);细胞系, 肿瘤(Cell Line, Tumor);疾病模型, 动物(Disease Models, Animal);基因表达(Gene Expression);遗传载体(Genetic Vectors);组织相容性抗原Ⅰ类(Histocompatibility Antigens Class I);人类(Humans);免疫调节(Immunomodulation);注射, 病灶内(Injections, Intralesional);干扰素γ(Interferon-gamma);干扰素类(Interferons);白细胞介素12(Interleukin-12);白细胞介素类(Interleukins);黑色素瘤, 实验性(Melanoma, Experimental);小鼠(Mice);小鼠, 基因敲除(Mice, Knockout);肿瘤(Neoplasms);T淋巴细胞亚群(T-Lymphocyte Subsets);转导, 遗传(Transduction, Genetic);转基因(Transgenes);肿瘤负荷(Tumor Burden);异种移植模型抗肿瘤试验(Xenograft Model Antitumor Assays)

DOI 10.1038/cgt.2016.29

PMID 27561689

发布时间 2024-01-09

检索历史清除

Anti-tumor immunity elicited by direct intratumoral administration of a recombinant adenovirus expressing either IL-28A/IFN-λ2 or IL-29/IFN-λ1.

Cancer gene therapy

相似文献

同项目论文

Cancer gene therapy

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Anti-tumor immunity elicited by direct intratumoral administration of a recombinant adenovirus expressing either IL-28A/IFN-λ2 or IL-29/IFN-λ1.

Cancer gene therapy

相似文献

同项目论文

Cancer gene therapy

相关期刊

检索历史清除